BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33762273)

  • 1. Coexistence of medium chain acyl-CoA dehydrogenase deficiency (MCADD) and type 1 diabetes (T1D): a management challenge.
    Afreh-Mensah D; Agwu JC
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33762273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medium-chain acyl-Coenzyme A dehydrogenase deficiency (MCADD): a cause of severe hypoglycaemia in an apparently well child.
    Maduemem KE
    BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27903579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Young Female With Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): A Case Report.
    Yusuf IQ; Venkatesan A; Okafor FC; Yasin A; Oyibo SO
    Cureus; 2023 Mar; 15(3):e36018. PubMed ID: 36915399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medium-chain Acyl-COA dehydrogenase deficiency: Pathogenesis, diagnosis, and treatment.
    Mason E; Hindmarch CCT; Dunham-Snary KJ
    Endocrinol Diabetes Metab; 2023 Jan; 6(1):e385. PubMed ID: 36300606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management Principles for Acute Illness in Patients With Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency.
    McGregor TL; Berry SA; Dipple KM; Hamid R;
    Pediatrics; 2021 Jan; 147(1):. PubMed ID: 33372121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoketotic hypoglycemia with myolysis and hypoparathyroidism: an unusual association in medium chain acyl-CoA desydrogenase deficiency (MCADD).
    Baruteau J; Levade T; Redonnet-Vernhet I; Mesli S; Bloom MC; Broué P
    J Pediatr Endocrinol Metab; 2009 Dec; 22(12):1175-7. PubMed ID: 20333879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalised modelling of clinical heterogeneity between medium-chain acyl-CoA dehydrogenase patients.
    Odendaal C; Jager EA; Martines AMF; Vieira-Lara MA; Huijkman NCA; Kiyuna LA; Gerding A; Wolters JC; Heiner-Fokkema R; van Eunen K; Derks TGJ; Bakker BM
    BMC Biol; 2023 Sep; 21(1):184. PubMed ID: 37667308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medium chain acyl-CoA dehydrogenase deficiency human genome epidemiology review.
    Wang SS; Fernhoff PM; Hannon WH; Khoury MJ
    Genet Med; 1999; 1(7):332-9. PubMed ID: 11263545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up of fatty acid β-oxidation disorders in expanded newborn screening era.
    Janeiro P; Jotta R; Ramos R; Florindo C; Ventura FV; Vilarinho L; Tavares de Almeida I; Gaspar A
    Eur J Pediatr; 2019 Mar; 178(3):387-394. PubMed ID: 30617651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden death in medium chain acyl-coenzyme a dehydrogenase deficiency (MCADD) despite newborn screening.
    Yusupov R; Finegold DN; Naylor EW; Sahai I; Waisbren S; Levy HL
    Mol Genet Metab; 2010 Sep; 101(1):33-9. PubMed ID: 20580581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) in the UK.
    Goddard P
    J Fam Health Care; 2004; 14(4):90-2. PubMed ID: 15453442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal rates of whole-body fat oxidation and gluconeogenesis after overnight fasting and moderate-intensity exercise in patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Huidekoper HH; Ackermans MT; Koopman R; van Loon LJ; Sauerwein HP; Wijburg FA
    J Inherit Metab Dis; 2013 Sep; 36(5):831-40. PubMed ID: 22976767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective review of anesthesia and perioperative care in children with medium-chain acyl-CoA dehydrogenase deficiency.
    Allen C; Perkins R; Schwahn B
    Paediatr Anaesth; 2017 Jan; 27(1):60-65. PubMed ID: 27896927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening for medium chain acyl CoA dehydrogenase deficiency.
    Leonard JV; Dezateux C
    Arch Dis Child; 2009 Mar; 94(3):235-8. PubMed ID: 18838415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype and residual enzyme activity in medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Are predictions possible?
    Tucci S; Wagner C; Grünert SC; Matysiak U; Weinhold N; Klein J; Porta F; Spada M; Bordugo A; Rodella G; Furlan F; Sajeva A; Menni F; Spiekerkoetter U
    J Inherit Metab Dis; 2021 Jul; 44(4):916-925. PubMed ID: 33580884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, biochemical and genetic analyses in two Korean patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Woo HI; Park HD; Lee YW; Lee DH; Ki CS; Lee SY; Kim JW
    Korean J Lab Med; 2011 Jan; 31(1):54-60. PubMed ID: 21239873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario.
    Kennedy S; Potter BK; Wilson K; Fisher L; Geraghty M; Milburn J; Chakraborty P
    BMC Pediatr; 2010 Nov; 10():82. PubMed ID: 21083904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult presentations of medium-chain acyl-CoA dehydrogenase deficiency (MCADD).
    Lang TF
    J Inherit Metab Dis; 2009 Dec; 32(6):675-683. PubMed ID: 19821147
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.